NCT00006375View on ClinicalTrials.gov

LY293111 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

LY293111

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

11030

North Shore University Hospital, Manhasset

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006375 - LY293111 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter